USPTO serial 99795364
FFF ENTERPRISES
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- CHMIELARSKI, ANDREW J
- Law office
- TMO LAW OFFICE 125
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with FFF ENTERPRISES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Marjorie Witter Norman
Marjorie Witter Norman Reed Smith LLP1901 Avenue of the Stars, Suite 700Los Angeles, CA 90067United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Supplying pharmaceuticals, biopharmaceuticals, human blood products, plasma products, and vaccines to healthcare providers, hospitals, and pharmacies; Distribution of pharmaceuticals, biopharmaceuticals, human blood products, plasma products, and vaccines; Consulting services related to procurement, reimbursement, and distribution in the field of pharmaceuticals, biopharmaceuticals, human blood products, plasma products, vaccines, and specialty pharmacy; Management services provided to healthcare providers, hospitals, and pharmacies for controlling inventory of pharmaceuticals, biopharmaceuticals, human blood products, plasma products, and vaccines; Procurement services, namely, procurement of pharmaceuticals, biopharmaceuticals, human blood products, plasma products, and vaccines for others; Wholesale store services for pharmaceuticals, biopharmaceuticals, human blood products, plasma products, medical supplies, and vaccines; Providing information concerning product recalls in the field of pharmaceuticals, biopharmaceuticals, human blood products, plasma products, and vaccines; Providing tracking services and information concerning tracking of assets in transit, namely, pharmaceuticals, biopharmaceuticals, human blood products, plasma products, and vaccines; Providing information concerning supply chain and patient safety in the field of pharmaceuticals, biopharmaceuticals, human blood products, plasma products, and vaccines; Providing information in the field of pharmaceuticals, biopharmaceuticals, human blood products, plasma products, and vaccines | ACTIVE | Jul 8, 1988 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 15, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 15, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 15, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 2, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 31, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 29, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 29, 2026 | NWAP | NEW APPLICATION ENTERED | — |